MRI Reveals That Early Changes in Cerebral Blood Volume Precede Blood–Brain Barrier Breakdown and Overt Pathology in MS-like Lesions in Rat Brain

Magnetic resonance imaging (MRI) is an established clinical tool for diagnosing multiple sclerosis (MS), the archetypal central nervous system neuroinflammatory disease. In this study, we have used a model of delayed-type hypersensitivity in the rat brain, which bears many of the hallmarks of an MS lesion, to investigate the development of MRI-detectable changes before the appearance of conventional indices of lesion development. In addition, we have correlated the MRI-detectable changes with the developing histopathology. Significant increases in regional cerebral blood volume (rCBV) preceded overt changes in blood–brain barrier (BBB) permeability, T2 relaxation and the diffusion properties of tissue water. Thus, changes in rCBV might be a more sensitive indicator of lesion onset than the conventional indices used clinically in MS patients, such as contrast enhancement. In addition, we show that BBB breakdown, and consequent edema formation, are more closely correlated with astrogliosis than any other histopathologic changes, while regions of T1 and T2 hypointensity appear to reflect hypercellularity.

[1]  N. Jagannathan,et al.  Sequential diffusion‐weighted magnetic resonance imaging study of lysophosphatidyl choline‐induced experimental demyelinating lesion: An animal model of multiple sclerosis , 2002, Journal of magnetic resonance imaging : JMRI.

[2]  H. Lassmann,et al.  Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. , 2000, The American journal of pathology.

[3]  T. Richards,et al.  Diffusion imaging of experimental allergic encephalomyelitis , 1993, Magnetic resonance in medicine.

[4]  F Barkhof,et al.  Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. , 1997, Magnetic resonance imaging.

[5]  H Okazaki,et al.  Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. , 1991, Radiology.

[6]  A. Thompson,et al.  Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration , 1992, Neurology.

[7]  Aaron J. Johnson,et al.  Disappearing "T1 black holes" in an animal model of multiple sclerosis. , 2004, Frontiers in bioscience : a journal and virtual library.

[8]  E. Döpp,et al.  The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. , 1985, Immunology.

[9]  S. Reingold,et al.  The role of magnetic resonance techniques in understanding and managing multiple sclerosis. , 1998, Brain : a journal of neurology.

[10]  J K Udupa,et al.  Computer-assisted quantitation of enhancing lesions in multiple sclerosis: correlation with clinical classification. , 1997, AJNR. American journal of neuroradiology.

[11]  Frauke Zipp,et al.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.

[12]  A. Haase,et al.  Rapid NMR imaging of dynamic processes using the FLASII technique , 1986, Magnetic resonance in medicine.

[13]  Roland Martin,et al.  Using gadolinium‐enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis , 1992, Annals of neurology.

[14]  H. Lassmann,et al.  Histopathological characterization of magnetic resonance imaging-detectable brain white matter lesions in a primate model of multiple sclerosis: a correlative study in the experimental autoimmune encephalomyelitis model in common marmosets (Callithrix jacchus). , 1998, The American journal of pathology.

[15]  F. Barkhof,et al.  Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. , 1998, AJNR. American journal of neuroradiology.

[16]  S. Karlik,et al.  Correlation between MRI and clinico-pathological manifestations in Lewis rats protected from experimental allergic encephalomyelitis by acylated synthetic peptide of myelin basic protein. , 1999, Magnetic resonance imaging.

[17]  S. Hsu,et al.  The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. , 1981, American journal of clinical pathology.

[18]  J. Frank,et al.  Serial MR imaging of experimental autoimmune encephalomyelitis induced by human white matter or by chimeric myelin-basic and proteolipid protein in the common marmoset. , 1999, AJNR. American journal of neuroradiology.

[19]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[20]  J. Chan,et al.  Tumefactive demyelinating lesions by combined perfusion-weighted and diffusion weighted imaging. , 2002, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[21]  S. LeVine,et al.  Iron deposits in the central nervous system of SJL mice with experimental allergic encephalomyelitis. , 1998, Life sciences.

[22]  T. Ptak,et al.  Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. , 1999, AJNR. American journal of neuroradiology.

[23]  Woolley,et al.  T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases. , 2001, Brain : a journal of neurology.

[24]  R. Petersen,et al.  Experimental allergic encephalomyelitis in non‐human primates: mri and mrs may predict the type of brain damage , 1995, NMR in biomedicine.

[25]  R. Bakshi,et al.  Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients , 2001, Journal of the Neurological Sciences.

[26]  D. N. Landon,et al.  Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. , 1990, Brain : a journal of neurology.

[27]  R. Grossman,et al.  Magnetization transfer effects in MR-detected multiple sclerosis lesions: comparison with gadolinium-enhanced spin-echo images and nonenhanced T1-weighted images. , 1995, AJNR. American journal of neuroradiology.

[28]  M Cercignani,et al.  Weekly diffusion-weighted imaging of normal-appearing white matter in MS , 2000, Neurology.

[29]  F. Barkhof,et al.  Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis. , 2001, Archives of neurology.

[30]  G J Barker,et al.  The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: a serial diffusion MRI study. , 2000, Brain : a journal of neurology.

[31]  F Barkhof,et al.  Development of hypointense lesions on T1-weighted spin-echo magnetic resonance images in multiple sclerosis: relation to inflammatory activity. , 1999, Archives of neurology.

[32]  C. Thomsen,et al.  Increased water self‐diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis , 1993, Acta neurologica Scandinavica.

[33]  R. Ordidge,et al.  Correction of motional artifacts in diffusion-weighted MR images using navigator echoes. , 1994, Magnetic resonance imaging.

[34]  P. Basser,et al.  MR diffusion tensor spectroscopy and imaging. , 1994, Biophysical journal.

[35]  G. B. Pike,et al.  Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. , 2000, Radiology.

[36]  M Filippi,et al.  Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis , 1998, Annals of neurology.

[37]  P M Matthews,et al.  Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis? , 1999, Brain : a journal of neurology.

[38]  H F McFarland,et al.  The lesion in multiple sclerosis: clinical, pathological, and magnetic resonance imaging considerations. , 1998, Journal of neurology, neurosurgery, and psychiatry.

[39]  A Van der Linden,et al.  In vivo noninvasive determination of abnormal water diffusion in the rat brain studied in an animal model for multiple sclerosis by diffusion-weighted NMR imaging. , 1996, Magnetic resonance imaging.

[40]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[41]  H P Hartung,et al.  In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. , 1996, Brain : a journal of neurology.

[42]  J. Taubenberger,et al.  Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.

[43]  B E Kendall,et al.  Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. , 1990, Brain : a journal of neurology.

[44]  F. Barkhof,et al.  Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis. , 1993, Brain : a journal of neurology.

[45]  J K Udupa,et al.  Differences between relapsing-remitting and chronic progressive multiple sclerosis as determined with quantitative MR imaging. , 1999, Radiology.

[46]  F. Barkhof,et al.  Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. , 2001, Brain : a journal of neurology.

[47]  Hans Lassmann,et al.  Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology , 1997, Annals of neurology.

[48]  Steven M LeVine,et al.  Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.

[49]  F. Barkhof,et al.  Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis , 1998, Neurology.

[50]  D. Li,et al.  Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis , 1994, Annals of neurology.

[51]  V. Perry,et al.  Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guérin , 1995, Neuroscience.

[52]  K. Scheffler,et al.  Dynamic susceptibility contrast MR imaging of plaque development in multiple sclerosis: Application of an extended blood‐brain barrier leakage correction , 2000, Journal of magnetic resonance imaging : JMRI.

[53]  O. Paulson,et al.  Regional cerebral blood flow in acute experimental allergic encephalomyelitis , 1986, Brain Research.

[54]  David H. Miller,et al.  Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance , 1996, Magnetic resonance in medicine.

[55]  C. Lucchinetti,et al.  A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions , 2001, Annals of neurology.

[56]  C. Thomsen,et al.  In vivo magnetic resonance diffusion measurement in the brain of patients with multiple sclerosis. , 1992, Magnetic resonance imaging.

[57]  A J Thompson,et al.  Correlations between changes in disability and T2‐weighted brain MRI activity in multiple sclerosis , 1995, Neurology.

[58]  T. Iwasawa,et al.  Diffusion‐weighted imaging of the human optic nerve: A New approach to evaluate optic neuritis in multiple sclerosis , 1997, Magnetic resonance in medicine.

[59]  G J Barker,et al.  Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. , 1999, Magnetic resonance imaging.

[60]  S Ropele,et al.  Quantitative magnetization transfer imaging of pre-lesional white-matter changes in multiple sclerosis , 2002, Multiple sclerosis.